Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination immunization regimen consisting of multiple pediatric vaccines administered together. The components are: - **DTaP-IPV-Hep B-PRP~T**: A pentavalent or hexavalent combination vaccine that protects against diphtheria, tetanus, acellular pertussis (whooping cough), inactivated poliovirus, hepatitis B virus and Haemophilus influenzae type b. The PRP-T component refers to the polyribosyl-ribitol-phosphate–tetanus toxoid conjugate used for Hib protection. Mechanism of action is induction of active immunity by stimulating antibody production against each pathogen[1][5]. - **Prevenar**: Brand name for Prevenar 13, a pneumococcal polysaccharide conjugate vaccine covering 13 serotypes of Streptococcus pneumoniae. It works by inducing antibodies to the capsular polysaccharides[6]. - **Rotarix**: An oral live attenuated rotavirus vaccine that induces mucosal and systemic immunity against rotavirus gastroenteritis. - **Infanrix hexa**: A hexavalent combination vaccine containing DTaP (diphtheria-tetanus-acellular pertussis), IPV (inactivated poliovirus), Hib (Haemophilus influenzae type b) and hepatitis B antigens. These vaccines are primarily indicated for routine immunization in infants and young children to prevent serious bacterial and viral infections including diphtheria, tetanus, pertussis, polio, hepatitis B infection, invasive Hib disease, pneumococcal disease and rotavirus gastroenteritis[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on DTaP-IPV-Hep B-PRP~T + Prevenar + Rotarix + Infanrix hexa.